Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
- 18 September 2004
- Vol. 23 (8) , 1029-1036
- https://doi.org/10.1016/j.vaccine.2004.07.043
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccinesGene Therapy, 2003
- Eight-plasmid system for rapid generation of influenza virus vaccinesVaccine, 2002
- Realities and enigmas of human viral influenza: pathogenesis, epidemiology and controlVaccine, 2002
- Preparation of vaccines against H5N1 influenzaVaccine, 2002
- Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoproteinVeterinary Microbiology, 2002
- Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous VaccinesJournal of Virology, 2001
- Generation of influenza A viruses entirely from cloned cDNAsProceedings of the National Academy of Sciences, 1999
- Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral ParticlesHuman Gene Therapy, 1997
- Egg Fluids and Cells of the Chorioallantoic Membrane of Embryonated Chicken Eggs Can Select Different Variants of Influenza A (H3N2) VirusesVirology, 1995
- Examination of Parameters Affecting the Elicitation of Humoral Immune Responses by Particle Bombardment-Mediated Genetic ImmunizationDNA and Cell Biology, 1993